{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["DNA condensation", "DNA damage", "DNA repair", "Ouabain", "human osteosarcoma cancer U-2 OS cells"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34410957", "DateCompleted": {"Year": "2021", "Month": "08", "Day": "23"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "15"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.21873/invivo.12552"], "Journal": {"ISSN": "1791-7549", "JournalIssue": {"Volume": "35", "Issue": "5", "PubDate": {"Year": "2021", "Season": "Sep-Oct"}}, "Title": "In vivo (Athens, Greece)", "ISOAbbreviation": "In Vivo"}, "ArticleTitle": "Ouabain Induces DNA Damage in Human Osteosarcoma U-2 OS Cells and Alters the Expression of DNA Damage and DNA Repair-associated Proteins.", "Pagination": {"StartPage": "2687", "EndPage": "2696", "MedlinePgn": "2687-2696"}, "Abstract": {"AbstractText": ["Ouabain, isolated from natural plants, exhibits anticancer activities; however, no report has presented its mechanism of DNA damage induction in human osteosarcoma cancer cells in vitro. The aim of this study was to investigate whether ouabain induces DNA damage and repair, accompanied with molecular pathways in human osteosarcoma cancer U-2 OS cells in vitro.", "The percentage of viable cell number was measured by flow cytometric assay; DNA damage was assayed by DAPI staining, comet assay, and agarose gel electrophoresis. DNA damage and repair associated protein expressions were assayed by western blotting assays.", "Ouabain reduced total cell viability, induced chromatin condensation, DNA fragmentation, and DNA damage in U-2 OS cells. Ouabain increased p-ATM<sup>Ser1981</sup>, p-ATR<sup>Ser428</sup>, and p53 at 2.5-10 \u03bcM, increased p-p53<sup>Ser15</sup> at 10 \u03bcM; however, it decreased p-MDM2<sup>Ser166</sup> at 2.5-10 \u03bcM. Ouabain increased p-H2A.X<sup>Ser139</sup>, MDC-1, and PARP at 2.5-10 \u03bcM and BRCA1 at 5-10 \u03bcM; however, it decreased DNA-PK and MGMT at 2.5-10 \u03bcM in U-2 OS cells at 48 h treatment. Ouabain promoted expression and nuclear translocation of p-H2A.X<sup>Ser139</sup> in U-2 OS cells and this was confirmed by confocal laser microscopy.", "Ouabain reduced total viable cell number through triggering DNA damage and altering the protein expression of DNA damage and repair system in U-2 OS cells in vitro."], "CopyrightInformation": "Copyright \u00a9 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nursing, Saint Mary's Junior College of Medicine, Nursing and Management, Yilan, Taiwan, R.O.C."}], "LastName": "Yang", "ForeName": "Jiun-Long", "Initials": "JL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, China Medical University Hospital, Taichung, Taiwan, R.O.C."}], "LastName": "Yang", "ForeName": "Mei-Due", "Initials": "MD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Botany and Health Applications, Da-Yeh University, Changhua, Taiwan, R.O.C."}], "LastName": "Chen", "ForeName": "Jaw-Chyun", "Initials": "JC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chinese Medicine, School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung, Taiwan, R.O.C."}], "LastName": "Lu", "ForeName": "Kung-Wen", "Initials": "KW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, School of Medicine, China Medical University, Taichung, Taiwan, R.O.C."}], "LastName": "Huang", "ForeName": "Yi-Ping", "Initials": "YP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C."}, {"Identifier": [], "Affiliation": "Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C."}], "LastName": "Peng", "ForeName": "Shu-Fen", "Initials": "SF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan, R.O.C."}], "LastName": "Chueh", "ForeName": "Fu-Shin", "Initials": "FS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan, R.O.C."}], "LastName": "Liu", "ForeName": "Kuo-Ching", "Initials": "KC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nursing, Saint Mary's Junior College of Medicine, Nursing and Management, Yilan, Taiwan, R.O.C."}, {"Identifier": [], "Affiliation": "Department of Pharmacy, Saint Mary's Hospital Luodong, Yilan, Taiwan, R.O.C."}], "LastName": "Lin", "ForeName": "Tzu-Shun", "Initials": "TS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C.; pychen@mail.cmu.edu.tw weijen128@yahoo.com.tw."}], "LastName": "Chen", "ForeName": "Po-Yuan", "Initials": "PY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedics, Chang Bing Show-Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.; pychen@mail.cmu.edu.tw weijen128@yahoo.com.tw."}, {"Identifier": [], "Affiliation": "Department of Orthopedics, Show-Chwan Memorial Hospital, Changhua, Taiwan, R.O.C."}], "LastName": "Chen", "ForeName": "Wei-Jen", "Initials": "WJ"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "In Vivo", "NlmUniqueID": "8806809", "ISSNLinking": "0258-851X"}, "ChemicalList": [{"RegistryNumber": "5ACL011P69", "NameOfSubstance": "Ouabain"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug therapy", "genetics"], "DescriptorName": "Bone Neoplasms"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "DNA Damage"}, {"QualifierName": [], "DescriptorName": "DNA Repair"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "genetics"], "DescriptorName": "Osteosarcoma"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ouabain"}], "CoiStatement": "The Authors confirm that there are no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, J\u00fcrgens H, Winkler K. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20(3):776\u2013790. doi: 10.1200/JCO.2002.20.3.776.", "ArticleIdList": ["10.1200/JCO.2002.20.3.776", "11821461"]}, {"Citation": "Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009;115(7):1531\u20131543. doi: 10.1002/cncr.24121.", "ArticleIdList": ["10.1002/cncr.24121", "PMC2813207", "19197972"]}, {"Citation": "Finkel MP, Reilly CA Jr, Biskis BO. Pathogenesis of radiation and virus-induced bone tumors. Recent Results Cancer Res. 1976;(54):92\u2013103. doi: 10.1007/978-3-642-80997-2_7.", "ArticleIdList": ["10.1007/978-3-642-80997-2_7", "189372"]}, {"Citation": "Li X, Liu X, Fang J, Li H, Chen J. microRNA-363 plays a tumor suppressive role in osteosarcoma by directly targeting MAP2K4. Int J Clin Exp Med. 2015;8(11):20157\u201320167.", "ArticleIdList": ["PMC4723773", "26884928"]}, {"Citation": "Hansen MF, Seton M, Merchant A. Osteosarcoma in Paget\u2019s disease of bone. J Bone Miner Res. 2006;21 Suppl 2:P58\u2013P63. doi: 10.1359/jbmr.06s211.", "ArticleIdList": ["10.1359/jbmr.06s211", "17229010"]}, {"Citation": "Ottaviani G, Jaffe N. The etiology of osteosarcoma. Cancer Treat Res. 2009;152:15\u201332. doi: 10.1007/978-1-4419-0284-9_2.", "ArticleIdList": ["10.1007/978-1-4419-0284-9_2", "20213384"]}, {"Citation": "Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini G, M\u00fcller C, Tienghi A, Wiebe T, Comandone A, B\u00f6hling T, Del Prever AB, Brosj\u00f6 O, Bacci G, Saeter G, Italian and Scandinavian Sarcoma Groups Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol. 2005;23(34):8845\u20138852. doi: 10.1200/JCO.2004.00.5785.", "ArticleIdList": ["10.1200/JCO.2004.00.5785", "16246977"]}, {"Citation": "Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71\u201396. doi: 10.3322/CA.2007.0010.", "ArticleIdList": ["10.3322/CA.2007.0010", "18287387"]}, {"Citation": "Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3\u201313. doi: 10.1007/978-1-4419-0284-9_1.", "ArticleIdList": ["10.1007/978-1-4419-0284-9_1", "20213383"]}, {"Citation": "Han G, Wang Y, Bi W, Jia J, Wang W. MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma. Exp Ther Med. 2015;9(3):679\u2013684. doi: 10.3892/etm.2014.2161.", "ArticleIdList": ["10.3892/etm.2014.2161", "PMC4316987", "25667613"]}, {"Citation": "Schonn I, Hennesen J, Dartsch DC. Cellular responses to etoposide: cell death despite cell cycle arrest and repair of DNA damage. Apoptosis. 2010;15(2):162\u2013172. doi: 10.1007/s10495-009-0440-9.", "ArticleIdList": ["10.1007/s10495-009-0440-9", "20041303"]}, {"Citation": "Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research, Treatment of Cancer Brain Tumor and Radiotherapy Groups and National Cancer Institute of Canada Clinical Trials Group Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u2013996. doi: 10.1056/NEJMoa043330.", "ArticleIdList": ["10.1056/NEJMoa043330", "15758009"]}, {"Citation": "Kaina B, Christmann M, Naumann S, Roos WP. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair (Amst) 2007;6(8):1079\u20131099. doi: 10.1016/j.dnarep.2007.03.008.", "ArticleIdList": ["10.1016/j.dnarep.2007.03.008", "17485253"]}, {"Citation": "Zhao H, Albino AP, Jorgensen E, Traganos F, Darzynkiewicz Z. DNA damage response induced by tobacco smoke in normal human bronchial epithelial and A549 pulmonary adenocarcinoma cells assessed by laser scanning cytometry. Cytometry A. 2009;75(10):840\u2013847. doi: 10.1002/cyto.a.20778.", "ArticleIdList": ["10.1002/cyto.a.20778", "PMC2814777", "19658174"]}, {"Citation": "Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell. 2010;40(2):179\u2013204. doi: 10.1016/j.molcel.2010.09.019.", "ArticleIdList": ["10.1016/j.molcel.2010.09.019", "PMC2988877", "20965415"]}, {"Citation": "Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461(7267):1071\u20131078. doi: 10.1038/nature08467.", "ArticleIdList": ["10.1038/nature08467", "PMC2906700", "19847258"]}, {"Citation": "Smith J, Tho LM, Xu N, Gillespie DA. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res. 2010;108:73\u2013112. doi: 10.1016/B978-0-12-380888-2.00003-0.", "ArticleIdList": ["10.1016/B978-0-12-380888-2.00003-0", "21034966"]}, {"Citation": "Schoner W, Bauer N, M\u00fcller-Ehmsen J, Kr\u00e4mer U, Hambarchian N, Schwinger R, Moeller H, Kost H, Weitkamp C, Schweitzer T, Kirch U, Neu H, Gr\u00fcnbaum EG. Ouabain as a mammalian hormone. Ann N Y Acad Sci. 2003;986:678\u2013684. doi: 10.1111/j.1749-6632.2003.tb07282.x.", "ArticleIdList": ["10.1111/j.1749-6632.2003.tb07282.x", "12763918"]}, {"Citation": "Schoner W, Scheiner-Bobis G. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer. Semin Nephrol. 2005;25(5):343\u2013351. doi: 10.1016/j.semnephrol.2005.03.010.", "ArticleIdList": ["10.1016/j.semnephrol.2005.03.010", "16139690"]}, {"Citation": "Cereijido M, Contreras RG, Shoshani L, Larre I. The Na+-K+-ATPase as self-adhesion molecule and hormone receptor. Am J Physiol Cell Physiol. 2012;302(3):C473\u2013C481. doi: 10.1152/ajpcell.00083.2011.", "ArticleIdList": ["10.1152/ajpcell.00083.2011", "22049208"]}, {"Citation": "Nicholls MG, Lewis LK, Yandle TG, Lord G, McKinnon W, Hilton PJ. Ouabain, a circulating hormone secreted by the adrenals, is pivotal in cardiovascular disease. Fact or fantasy? J Hypertens. 2009;27(1):3\u20138. doi: 10.1097/HJH.0b013e32831101d1.", "ArticleIdList": ["10.1097/HJH.0b013e32831101d1", "19050442"]}, {"Citation": "Zhang L, Zhang Z, Guo H, Wang Y. Na+/K+-ATPase-mediated signal transduction and Na+/K+-ATPase regulation. Fundam Clin Pharmacol. 2008;22(6):615\u2013621. doi: 10.1111/j.1472-8206.2008.00620.x.", "ArticleIdList": ["10.1111/j.1472-8206.2008.00620.x", "19049666"]}, {"Citation": "Nesher M, Dvela M, Igbokwe VU, Rosen H, Lichtstein D. Physiological roles of endogenous ouabain in normal rats. Am J Physiol Heart Circ Physiol. 2009;297(6):H2026\u2013H2034. doi: 10.1152/ajpheart.00734.2009.", "ArticleIdList": ["10.1152/ajpheart.00734.2009", "19837951"]}, {"Citation": "Fedorova OV, Shapiro JI, Bagrov AY. Endogenous cardiotonic steroids and salt-sensitive hypertension. Biochim Biophys Acta. 2010;1802(12):1230\u20131236. doi: 10.1016/j.bbadis.2010.03.011.", "ArticleIdList": ["10.1016/j.bbadis.2010.03.011", "PMC2933321", "20347967"]}, {"Citation": "Prassas I, Diamandis EP. Novel therapeutic applications of cardiac glycosides. Nat Rev Drug Discov. 2008;7(11):926\u2013935. doi: 10.1038/nrd2682.", "ArticleIdList": ["10.1038/nrd2682", "18948999"]}, {"Citation": "Kong D, Li J, Zhao B, Xia B, Zhang L, He Y, Wang X, Gao L, Wang Y, Jin X, Lou G. The effect of SCF and ouabain on small intestinal motility dysfunction induced by gastric cancer peritoneal metastasis. Clin Exp Metastasis. 2015;32(3):267\u2013277. doi: 10.1007/s10585-015-9702-9.", "ArticleIdList": ["10.1007/s10585-015-9702-9", "25689893"]}, {"Citation": "Newman RA, Yang P, Pawlus AD, Block KI. Cardiac glycosides as novel cancer therapeutic agents. Mol Interv. 2008;8(1):36\u201349. doi: 10.1124/mi.8.1.8.", "ArticleIdList": ["10.1124/mi.8.1.8", "18332483"]}, {"Citation": "Kobayakawa J, Sato-Nishimori F, Moriyasu M, Matsukawa Y. G2-M arrest and antimitotic activity mediated by casticin, a flavonoid isolated from Viticis Fructus (Vitex rotundifolia Linne fil.) Cancer Lett. 2004;208(1):59\u201364. doi: 10.1016/j.canlet.2004.01.012.", "ArticleIdList": ["10.1016/j.canlet.2004.01.012", "15105046"]}, {"Citation": "Chanvorachote P, Pongrakhananon V. Ouabain downregulates Mcl-1 and sensitizes lung cancer cells to TRAIL-induced apoptosis. Am J Physiol Cell Physiol. 2013;304(3):C263\u2013C272. doi: 10.1152/ajpcell.00225.2012.", "ArticleIdList": ["10.1152/ajpcell.00225.2012", "23174563"]}, {"Citation": "Chang YM, Shih YL, Chen CP, Liu KL, Lee MH, Lee MZ, Hou HT, Huang HC, Lu HF, Peng SF, Chen KW, Yeh MY, Chung JG. Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways. Environ Toxicol. 2019;34(12):1329\u20131339. doi: 10.1002/tox.22834.", "ArticleIdList": ["10.1002/tox.22834", "31436044"]}, {"Citation": "Tang SY, Zhong MZ, Yuan GJ, Hou SP, Yin LL, Jiang H, Yu Z\u03a5. Casticin, a flavonoid, potentiates TRAIL-induced apoptosis through modulation of anti-apoptotic proteins and death receptor 5 in colon cancer cells. Oncol Rep. 2013;29(2):474\u2013480. doi: 10.3892/or.2012.2127.", "ArticleIdList": ["10.3892/or.2012.2127", "23135489"]}, {"Citation": "Xiao Y, Meng C, Lin J, Huang C, Zhang X, Long Y, Huang Y, Lin Y. Ouabain targets the Na+/K+-ATPase \u03b13 isoform to inhibit cancer cell proliferation and induce apoptosis. Oncol Lett. 2017;14(6):6678\u20136684. doi: 10.3892/ol.2017.7070.", "ArticleIdList": ["10.3892/ol.2017.7070", "PMC5688790", "29163695"]}, {"Citation": "da Silva JMC, Azevedo ADN, Barbosa RPDS, Teixeira MP, Vianna TAG, Fittipaldi J, Cabral VR, Paiva LS. Ouabain Decreases Regulatory T Cell Number in Mice by Reducing IL-2 Secretion. Neuroimmunomodulation. 2019;26(4):188\u2013197. doi: 10.1159/000501720.", "ArticleIdList": ["10.1159/000501720", "31412342"]}, {"Citation": "Chueh FS, Chen YY, Huang AC, Ho HC, Liao CL, Yang JS, Kuo CL, Chung JG. Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways. Environ Toxicol. 2014;29(1):21\u201329. doi: 10.1002/tox.20769.", "ArticleIdList": ["10.1002/tox.20769", "21922632"]}, {"Citation": "Lee CF, Chiang NN, Lu YH, Huang YS, Yang JS, Tsai SC, Lu CC, Chen FA. Benzyl isothiocyanate (BITC) triggers mitochondria-mediated apoptotic machinery in human cisplatin-resistant oral cancer CAR cells. Biomedicine (Taipei) 2018;8(3):15. doi: 10.1051/bmdcn/2018080315.", "ArticleIdList": ["10.1051/bmdcn/2018080315", "PMC6108226", "30141402"]}, {"Citation": "Shih YL, Chou J, Yeh MY, Chou HM, Chou HC, Lu HF, Shang HS, Chueh FS, Chu YL, Hsueh SC, Chung JG. Casticin induces DNA damage and inhibits DNA repair-associated protein expression in B16F10 mouse melanoma cancer cells. Oncol Rep. 2016;36(4):2094\u20132100. doi: 10.3892/or.2016.5027.", "ArticleIdList": ["10.3892/or.2016.5027", "27572101"]}, {"Citation": "Kuo JH, Shih TY, Lin JP, Lai KC, Lin ML, Yang MD, Chung JG. Cantharidin induces DNA damage and inhibits DNA repair-associated protein expressions in TSGH8301 human bladder cancer cell. Anticancer Res. 2015;35(2):795\u2013804.", "ArticleIdList": ["25667459"]}, {"Citation": "McCloskey DE, Kaufmann SH, Prestigiacomo LJ, Davidson NE. Paclitaxel induces programmed cell death in MDA-MB-468 human breast cancer cells. Clin Cancer Res. 1996;2(5):847\u2013854.", "ArticleIdList": ["9816240"]}, {"Citation": "Hu L, Hofmann J, Lu Y, Mills GB, Jaffe RB. Inhibition of phosphatidylinositol 3\u2019-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Cancer Res. 2002;62(4):1087\u20131092.", "ArticleIdList": ["11861387"]}, {"Citation": "Hentze H, Latta M, K\u00fcnstle G, Dhakshinamoorthy S, Ng PY, Porter AG, Wendel A. Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis. Hepatology. 2004;39(5):1311\u20131320. doi: 10.1002/hep.20174.", "ArticleIdList": ["10.1002/hep.20174", "15122760"]}, {"Citation": "Nesnow S, Argus M, Bergman H, Chu K, Frith C, Helmes T, McGaughy R, Ray V, Slaga TJ, Tennant R. Chemical carcinogens. A review and analysis of the literature of selected chemicals and the establishment of the Gene-Tox Carcinogen Data Base. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res. 1987;185(1-2):1\u2013195. doi: 10.1016/0165-1110(87)90017-0.", "ArticleIdList": ["10.1016/0165-1110(87)90017-0", "3540654"]}, {"Citation": "Barnes JL, Zubair M, John K, Poirier MC, Martin FL. Carcinogens and DNA damage. Biochem Soc Trans. 2018;46(5):1213\u20131224. doi: 10.1042/BST20180519.", "ArticleIdList": ["10.1042/BST20180519", "PMC6195640", "30287511"]}, {"Citation": "Chou WH, Liu KL, Shih YL, Chuang YY, Chou J, Lu HF, Jair HW, Lee MZ, Au MK, Chung JG. Ouabain induces apoptotic cell death through caspase- and mitochondria-dependent pathways in human osteosarcoma U-2 OS cells. Anticancer Res. 2018;38(1):169\u2013178. doi: 10.21873/anticanres.12205.", "ArticleIdList": ["10.21873/anticanres.12205", "29277770"]}, {"Citation": "Yang MY, Wang CJ, Chen NF, Ho WH, Lu FJ, Tseng TH. Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3. Chem Biol Interact. 2014;213:60\u201368. doi: 10.1016/j.cbi.2014.02.002.", "ArticleIdList": ["10.1016/j.cbi.2014.02.002", "24525192"]}, {"Citation": "Jakubowska J, Stasiak M, Szulawska A, Bednarek A, Czyz M. Combined effects of doxorubicin and STI571 on growth, differentiation and apoptosis of CML cell line K562. Acta Biochim Pol. 2007;54(4):839\u2013846.", "ArticleIdList": ["17957275"]}, {"Citation": "Soria G, Polo SE, Almouzni G. Prime, repair, restore: the active role of chromatin in the DNA damage response. Mol Cell. 2012;46(6):722\u2013734. doi: 10.1016/j.molcel.2012.06.002.", "ArticleIdList": ["10.1016/j.molcel.2012.06.002", "22749398"]}, {"Citation": "Papamichos-Chronakis M, Peterson CL. Chromatin and the genome integrity network. Nat Rev Genet. 2013;14(1):62\u201375. doi: 10.1038/nrg3345.", "ArticleIdList": ["10.1038/nrg3345", "PMC3731064", "23247436"]}, {"Citation": "Wu LY, Lu HF, Chou YC, Shih YL, Bau DT, Chen JC, Hsu SC, Chung JG. Kaempferol induces DNA damage and inhibits DNA repair associated protein expressions in human promyelocytic leukemia HL-60 cells. Am J Chin Med. 2015;43(2):365\u2013382. doi: 10.1142/S0192415X1550024X.", "ArticleIdList": ["10.1142/S0192415X1550024X", "25779644"]}, {"Citation": "De Zio D, Cianfanelli V, Cecconi F. New insights into the link between DNA damage and apoptosis. Antioxid Redox Signal. 2013;19(6):559\u2013571. doi: 10.1089/ars.2012.4938.", "ArticleIdList": ["10.1089/ars.2012.4938", "PMC3717195", "23025416"]}, {"Citation": "Norbury CJ, Zhivotovsky B. DNA damage-induced apoptosis. Oncogene. 2004;23(16):2797\u20132808. doi: 10.1038/sj.onc.1207532.", "ArticleIdList": ["10.1038/sj.onc.1207532", "15077143"]}, {"Citation": "Cheng Q, Chen J. Mechanism of p53 stabilization by ATM after DNA damage. Cell Cycle. 2010;9(3):472\u2013478. doi: 10.4161/cc.9.3.10556.", "ArticleIdList": ["10.4161/cc.9.3.10556", "PMC2977994", "20081365"]}, {"Citation": "Taylor AM, Metcalfe JA, Thick J, Mak YF. Leukemia and lymphoma in ataxia telangiectasia. Blood. 1996;87(2):423\u2013438.", "ArticleIdList": ["8555463"]}, {"Citation": "Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 1996;86(1):159\u2013171. doi: 10.1016/s0092-8674(00)80086-0.", "ArticleIdList": ["10.1016/s0092-8674(00)80086-0", "8689683"]}, {"Citation": "Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408(6810):307\u2013310. doi: 10.1038/35042675.", "ArticleIdList": ["10.1038/35042675", "11099028"]}, {"Citation": "Giaccia AJ, Kastan MB. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 1998;12(19):2973\u20132983. doi: 10.1101/gad.12.19.2973.", "ArticleIdList": ["10.1101/gad.12.19.2973", "9765199"]}, {"Citation": "Wang H, Nan L, Yu D, Agrawal S, Zhang R. Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms. Clin Cancer Res. 2001;7(11):3613\u20133624.", "ArticleIdList": ["11705884"]}, {"Citation": "Mah LJ, El-Osta A, Karagiannis TC. gammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia. 2010;24(4):679\u2013686. doi: 10.1038/leu.2010.6.", "ArticleIdList": ["10.1038/leu.2010.6", "20130602"]}, {"Citation": "Friedberg EC. DNA damage and repair. Nature. 2003;421(6921):436\u2013440. doi: 10.1038/nature01408.", "ArticleIdList": ["10.1038/nature01408", "12540918"]}, {"Citation": "Krieger KL, Hu WF, Ripperger T, Woods NT. Functional impacts of the BRCA1-mTORC2 interaction in breast cancer. Int J Mol Sci. 2019;20(23):5876. doi: 10.3390/ijms20235876.", "ArticleIdList": ["10.3390/ijms20235876", "PMC6928641", "31771139"]}, {"Citation": "Takaoka M, Miki Y. BRCA1 gene: function and deficiency. Int J Clin Oncol. 2018;23(1):36\u201344. doi: 10.1007/s10147-017-1182-2.", "ArticleIdList": ["10.1007/s10147-017-1182-2", "28884397"]}, {"Citation": "Shiloh Y, Ziv Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol. 2013;14(4):197\u2013210.", "ArticleIdList": ["23847781"]}, {"Citation": "Blackford AN, Jackson SP. ATM, ATR, and DNA-PK: The Trinity at the heart of the DNA damage response. Mol Cell. 2017;66(6):801\u2013817. doi: 10.1016/j.molcel.2017.05.015.", "ArticleIdList": ["10.1016/j.molcel.2017.05.015", "28622525"]}, {"Citation": "Rogakou EP, Boon C, Redon C, Bonner WM. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol. 1999;146(5):905\u2013916. doi: 10.1083/jcb.146.5.905.", "ArticleIdList": ["10.1083/jcb.146.5.905", "PMC2169482", "10477747"]}, {"Citation": "Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell. 2005;123(7):1213\u20131226. doi: 10.1016/j.cell.2005.09.038.", "ArticleIdList": ["10.1016/j.cell.2005.09.038", "16377563"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "6", "Day": "8"}, {"Year": "2021", "Month": "7", "Day": "14"}, {"Year": "2021", "Month": "7", "Day": "15"}, {"Year": "2021", "Month": "8", "Day": "19", "Hour": "17", "Minute": "23"}, {"Year": "2021", "Month": "8", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "3"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34410957", "PMC8408727", "10.21873/invivo.12552", "35/5/2687"]}}], "PubmedBookArticle": []}